Re: This gets me thinking Resverlogix is in sombody's sights.

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: This gets me thinking Resverlogix is in sombody's sights.

in response to

This gets me thinking Resverlogix is in sombody's sights.

coldnewfie

posted on Nov 16, 2016 04:54PM

Perhaps the earlier part of the sentence sheds some light...."the holders of the Royalty Preferred Shares are entitled to receive in respect of each such share........"

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply